The Effect of Microneedling With Low Energy Laser in Androgenic Alopecia Patients.

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03723369

Enrollment

Registered

2018-10-29

Start date

2018-10-30

Completion date

2019-12-30

Last updated

2020-01-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dermatologic Disease

Brief summary

Androgenetic alopecia is the most common type of hair loss in men, and affects approximately 50 percent of Caucasian men by age 50. The condition is characterized by the progressive loss of terminal hairs on the scalp in a characteristic distribution. The anterior scalp, mid scalp, temporal scalp, and vertex of the scalp are typical sites of involvement. Male balding and male pattern hair loss are additional terms used to refer to this condition. The aim of this study is to investigate the effect of microneedling in androgenic alopecia

Interventions

DEVICEaccupuncture

accupuncture

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

MALE

Age

20 Years to 60 Years

Healthy volunteers

Inclusion criteria

\- androgenic alopecia patients

Exclusion criteria

* infection, immune disorder, other dermatosis in treating areas

Design outcomes

Primary

Measure	Time frame	Description
hair regrowth(7-point rating scale (-3 = greatly decreased, -2 = moderately decreased, -1 = slightly decreased, 0 = no change, +1 = slightly increased, +2 = moderately increased, +3 = greatly increased).)	12weeks	hair regrowth(7-point rating scale (-3 = greatly decreased, -2 = moderately decreased, -1 = slightly decreased, 0 = no change, +1 = slightly increased, +2 = moderately increased, +3 = greatly increased).)

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026